NEW YORK, May 17 (GenomeWeb News) - RNAi therapeutics company Benitec has acquired startup Avocel and will make it its US subsidiary, the Queensland, Australia-based company said today.

 

Under the agreement, Benitec will issue 7.6 million shares to Avocel, representing approximately 9 percent of its enlarged share capital.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.